• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

ARVO 2008 program expected to draw more than 10,000 attendees with 39.5 hours of CME

Article

The ARVO meeting will feature more than a dozen minisymposia by the ARVO sections, education courses, workshops, special interest group sessions, and events aimed specifically at members-in-training.

The ARVO annual meeting, which offers 39.5 hours toward CME, is one of the world's largest forums for exploring techniques, protocols, and tools for improving patient care and vision and curing eye disease.

This year's ARVO/Alcon Laboratories keynote speaker will be inventor and author Ray Kurzweil, a leader in technologies such as the flatbed scanner with charge-coupled device and omni-font optical character recognition. He is the recipient of the Lemelson-MIT Prize, the world's largest award for innovation, as well as a 1999 National Medal of Technology.

Speakers Jean Bennett, MD, PhD; Brian P. Brooks, MD, PhD; Jonathan L. Haines, PhD; KE1ri StefE1nsson, MD; and Edwin Stone, MD, PhD, will offer perspectives for this year's basic/clinical lecture, "Genetics: bench to bedside."

The meeting also will feature more than a dozen minisymposia by the ARVO sections, education courses, workshops, special interest group sessions, and events aimed specifically at members-in-training.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.